

Publisher: Bentham Science Publishers
E-ISSN: 2212-389x|9|2|78-82
ISSN: 1574-3624
Source: Current Signal Transduction Therapy, Vol.9, Iss.2, 2014-08, pp. : 78-82
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Signal transduction has been acknowledged to be involved in various cell biological processes. And it is proved that multiple signaling pathways have been associated with the development and progression of pancreatic cancer, which remains one of the most devastating human diseases. Newly developed drugs targeting these aberrant signaling pathways show bright prospect in improving the therapeutic efficacy and outcome for patients with pancreatic cancer. Here we overview the pancreatic cancer related signaling pathway disorders and the corresponding promising targeted therapeutic regimens.
Related content


Signal Transduction Therapy for Cancer - Whither Now?
Current Signal Transduction Therapy, Vol. 1, Iss. 1, 2006-01 ,pp. :


Signal Transduction and Photodynamic Therapy
Current Signal Transduction Therapy, Vol. 3, Iss. 1, 2008-01 ,pp. :




Signal Transduction Targets in Prostate Cancer
Current Signal Transduction Therapy, Vol. 3, Iss. 2, 2008-01 ,pp. :